drugset / Trial / NCT07535190

Endometrial Immune Profile Changes After Autologous Intrauterine PRP Treatment

NCT07535190 ↗

Recruiting 50 enrolled Nadezhda Women's Health Hospital
NaSingle-groupOpen-labelTreatment

Summary

The success rate after treatment by in-vitro fertilisation (IVF) strongly depends on the endometrial receptivity, which in turn is strictly connected to the endometrial immune profile. IVF outcome is largely dependent upon endometrial immune cell ratios and their relationship with one another. During the last few years there are several studies and case reports for intrauterine PRP application in patients resulting in a thicker, regenerated endometrium and better immune cell population ratios. In this project, the investigators aim to analyze the effect of autologous intrauterine PRP administration on the endometrial immune profile, endometrial thickness, selected hormone levels (E2, P4) during the mid-luteal phase and IVF outcomes (biochemical and clinical pregnancy).

Timeline

Start
2026-01-19
Primary completion
2027-12
Completion
2028-06

Drugs

EvaluationDrugModalityDoseRoute
Subject Platelet rich plasma (PRP) Cell therapy 1.5 ml Other

Indications